Hypothesis: Antiplatelet effects of selective serotonin reuptake inhibitors cause clinical benefits on cardiovascular disease and increase risks of bleeding

Victor L. Serebruany, Christopher M. O'Connor, Ranga R. Krishnan, Charles H. Hennekens

Research output: Contribution to journalArticle

Original languageEnglish (US)
Pages (from-to)163-164
Number of pages2
JournalJournal of Cardiovascular Pharmacology and Therapeutics
Volume10
Issue number3
DOIs
Publication statusPublished - Sep 2005

ASJC Scopus subject areas

  • Pharmacology
  • Cardiology and Cardiovascular Medicine

Cite this